Novel applications of histopathological markers to distinguish prognostic subgroups in colorectal adenocarcinoma

Novel applications of histopathological markers to distinguish prognostic subgroups in colorectal adenocarcinoma

AbstractObjective To explore the novel applications of histological factors by stratifying the prognostic markers of the overall CRC patients in subgroups.Materials and methods A total of 17 histopathological and molecular factors were retrospectively collected and systematically analyzed for the pr...

Full description

Bibliographic Details
Main Authors:	Yuan Yuan, Weimin Ren, Jinchao Zhu, Saiyan Ji, Qingyuan Yang
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2023-12-01
Series:	Annals of Medicine
Subjects:	Colorectal adenocarcinoma prognostic biomarker Ki-67 expression KRAS mutation relapse precision pathology
Online Access:	https://www.tandfonline.com/doi/10.1080/07853890.2023.2244181

Similar Items

Avaliação da expressão da caspase-3 no adenocarcinoma colorretal através de um sistema computadorizado de análise de imagem Evaluation of caspase-3 markers expression in colorectal adenocarcinoma by a computadorized image analysis system
by: Monres José Gomes, et al.
Published: (2008-03-01)

Ki-67 proliferation index and clinicopathological patterns in colorectal carcinomas
by: Bhagya Lakshmi A, et al.
Published: (2015-04-01)

Expression of CDX-2 and Ki-67 in different grades of colorectal adenocarcinomas
by: Anway Sen, et al.
Published: (2015-01-01)

The relationships of OSBPL3 expression with KI-67 expression and KRAS mutations in CRC: implications for diagnosis and prognosis
by: Min Zhang, et al.
Published: (2022-12-01)

Clinical Significance and Prognostic Value of the Maximum Standardized Uptake Value of 18F-Flurodeoxyglucose Positron Emission Tomography–Computed Tomography in Colorectal Cancer
by: Yi-xin Yin, et al.
Published: (2021-12-01)

Prognostic Value of Ki67 and Other Clinical and Histopathological Factors in Canine Apocrine Gland Anal Sac Adenocarcinoma
by: Emanuela Maria Morello, et al.
Published: (2021-06-01)

A case of rapidly progressing and poorly differentiated Ip‐type early‐stage colorectal adenocarcinoma
by: Atsuko Tsubomoto, et al.
Published: (2023-04-01)

Biomarkers in Advanced Colorectal Cancer: Challenges in Translating Clinical Research into Practice
by: Hendrik-Tobias Arkenau, et al.
Published: (2011-04-01)

CEA-Ki-67- Pathologic Subtype: An Adjunct Factor for Refining Prognosis in Stage I Pulmonary Adenocarcinoma
by: Dongzhi Yu, et al.
Published: (2022-04-01)

Activation of the P38-MSK1 axis in colorectal adenocarcinoma determines a good prognostic outcome
by: Mariana F. Gayyed, et al.
Published: (2021-05-01)

Discordance of KRAS Mutational Status between Primary Tumors and Liver Metastases in Colorectal Cancer: Impact on Long-Term Survival Following Radical Resection
by: Francesco Ardito, et al.
Published: (2021-04-01)

C-MYC Protein Expression and High Ki-67 Proliferative Index are Predictives of Disease Relapse in Diffuse Large B Cell Lymphoma
by: Mahmoud Tag El-Hussien, et al.
Published: (2021-03-01)

A Randomised, Double Blind, Placebo-Controlled Pilot Study of Oral Artesunate Therapy for Colorectal Cancer
by: Sanjeev Krishna, et al.
Published: (2015-01-01)

Immunohistochemical Study of Tumor Cells Proliferative Activity at Different Graduations of Prostate Cancer
by: G. Y. Kudryavtsev, et al.
Published: (2019-12-01)

Evaluation of the proliferation marker Ki67 as a prognostic factor in patients with breast carcinoma
by: Fatima S. Al-Sarraf, et al.
Published: (2015-07-01)

Spectral CT Combined with Tumor Markers to Predict Ki-67 Expression in Lung Adenocarcinoma
by: Peipei DOU, et al.
Published: (2023-11-01)

Immunohistochemical study of P53 protein expression in different prostate cancer Gleason grading groups
by: G. Y. Kudryavtsev, et al.
Published: (2020-12-01)

Expression and Clinical Significance of the Thyroid Transcription Factor 1  in Xuanwei Lung Adenocarcinoma
by: Yunfen ZU, et al.
Published: (2013-03-01)

Effect of KRAS mutations and p53 expression on the postoperative prognosis of patients with colorectal cancer
by: Lingfeng Wang, et al.
Published: (2022-07-01)

A Machine-learning Approach for the Assessment of the Proliferative Compartment of Solid Tumors on Hematoxylin-Eosin-Stained Sections
by: Francesco Martino, et al.
Published: (2020-05-01)

Combined utility of Ki-67 index and tumor grade to stratify patients with pancreatic ductal adenocarcinoma who underwent upfront surgery
by: Bo Li, et al.
Published: (2023-12-01)

Incorporation of p-53 mutation status and Ki-67 proliferating index in classifying Her2-neu positive gastric adenocarcinoma
by: Ayesha Ahmed, et al.
Published: (2018-01-01)

Ki-67 protein expression and tumor associated inflammatory cells (macrophages and mast cells) in canine colorectal carcinoma
by: M. Woldemeskel, et al.
Published: (2017-04-01)

Microsatellite instability screening in colorectal carcinoma: immunohistochemical analysis of MMR proteins in correlation with clinicopathological features and Ki-67 protein expression
by: Noha N. Yassen, et al.
Published: (2023-10-01)

The prognostic significance of KRAS and BRAF mutation status in Korean colorectal cancer patients
by: Daeyoun David Won, et al.
Published: (2017-06-01)

Evaluation of KRAS Concomitant Mutations in Advanced Lung Adenocarcinoma Patients
by: Veronica Aran, et al.
Published: (2021-09-01)

Ki-67 and Bcl-2 in colorectal polyps with breast cancer
by: Ibrahim Gelincik
Published: (2011-01-01)

The prevalence of KRAS and BRAF mutation in colorectal cancer patients in Bali
by: Ayu Dewi Ni Nyoman, et al.
Published: (2022-03-01)

Study of the expression of oncoprotein p53, EGFR in colorectal carcinomas with different proliferative activity
by: I.S. Shponka, et al.
Published: (2023-04-01)

AI‐based intra‐tumor heterogeneity score of Ki67 expression as a prognostic marker for early‐stage ER+/HER2− breast cancer
by: Wenqi Lu, et al.
Published: (2024-01-01)

Imaging features associated with survival outcomes among colorectal cancer patients with and without KRAS mutation
by: Julaluck Promsorn, et al.
Published: (2021-01-01)

New Insights in the Diagnosis of Rare Adenocarcinoma Variants of the Cervix—Case Report and Review of Literature
by: Cristina Secosan, et al.
Published: (2022-07-01)

Immunohistochemical evaluation of BCL-2 and KI-67 proteins in colorectal adenoma.
by: Areege N. Abd, et al.
Published: (2014-07-01)

Somatic mutations in colorectal cancer: regional experience
by: Nikolai A. Ognerubov, et al.
Published: (2022-07-01)

Intestinal-type adenocarcinoma of the Bartholin gland: A case report and literature review
by: Javier Martín-Vallejo, et al.
Published: (2021-08-01)

Prognostic Nutritional Index Predicts Treatment Outcomes following Palliative Surgery for Colorectal Adenocarcinoma
by: Manabu Shimomura, et al.
Published: (2017-10-01)

Proliferative index using Ki-67 index in reactive mesothelial versus metastatic adenocarcinoma cells in serous fluid
by: Noushin Afshar Moghaddam, et al.
Published: (2012-01-01)

Prognostic Importance of Ki-67 in Breast Cancer and Its Relationship with Other Prognostic Factors
by: Gül Kanyılmaz, et al.
Published: (2019-10-01)

Practical value of MIB-1 index in predicting behavior of astrocytomas
by: M Moses Ambroise, et al.
Published: (2011-01-01)

A comparative histopathological and immunohistochemical study of Survivin and Ki-67 proteins in glial tumours
by: Nur Topyalin, et al.
Published: (2019-01-01)